Saedi Elham, Gheini Mohammad Reza, Faiz Firoozeh, Arami Mohammad Ali
Elham Saedi, Amir Alam Research Center, Department of Internal Medicine, Division of Neurology, Amir Alam Hospital, Tehran University of Medical Sciences, Tehran 1416753955, Iran.
World J Diabetes. 2016 Sep 15;7(17):412-22. doi: 10.4239/wjd.v7.i17.412.
There is strong evidence that diabetes mellitus increases the risk of cognitive impairment and dementia. Insulin signaling dysregulation and small vessel disease in the base of diabetes may be important contributing factors in Alzheimer's disease and vascular dementia pathogenesis, respectively. Optimal glycemic control in type 1 diabetes and identification of diabetic risk factors and prophylactic approach in type 2 diabetes are very important in the prevention of cognitive complications. In addition, hypoglycemic attacks in children and elderly should be avoided. Anti-diabetic medications especially Insulin may have a role in the management of cognitive dysfunction and dementia but further investigation is needed to validate these findings.
有强有力的证据表明,糖尿病会增加认知障碍和痴呆症的风险。糖尿病基础上的胰岛素信号失调和小血管疾病可能分别是阿尔茨海默病和血管性痴呆发病机制的重要促成因素。1型糖尿病的最佳血糖控制以及2型糖尿病危险因素的识别和预防方法对于预防认知并发症非常重要。此外,应避免儿童和老年人发生低血糖发作。抗糖尿病药物尤其是胰岛素可能在认知功能障碍和痴呆症的管理中发挥作用,但需要进一步研究来验证这些发现。